Advances on the therapeutic potential of cell receptor activation in glioblastoma
- PMID: 39907852
- DOI: 10.1007/s11033-025-10312-w
Advances on the therapeutic potential of cell receptor activation in glioblastoma
Abstract
Glioblastoma multiforme is the most common and aggressive malignant brain tumor. Current therapies have been unable to improve life expectancy in patients. This cancer is frequently accompanied by overexpression of receptors, such as EGFR, VEGFR and TLRs, involved in the regulation of inflammation, cell proliferation, differentiation, and survival. The present review summarizes current knowledge from preclinical and clinical studies investigating the role of pattern recognition and tyrosine kinase receptors in glioblastoma development and evolution, and their possible use to improve treatment outcomes and patient survival.
Keywords: Cell signaling pathways; Glioblastoma.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.Cells. 2019 Apr 12;8(4):350. doi: 10.3390/cells8040350. Cells. 2019. PMID: 31013819 Free PMC article. Review.
-
Targeting ErbB receptors in high-grade glioma.Curr Pharm Des. 2011;17(23):2468-87. doi: 10.2174/138161211797249233. Curr Pharm Des. 2011. PMID: 21827413 Review.
-
Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.Cancer Biol Ther. 2014 Feb;15(2):216-24. doi: 10.4161/cbt.26736. Epub 2013 Nov 1. Cancer Biol Ther. 2014. PMID: 24525857 Free PMC article.
-
Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.Cancer Invest. 2012 Jan;30(1):48-56. doi: 10.3109/07357907.2011.630050. Cancer Invest. 2012. PMID: 22236189 Free PMC article. Review.
-
MicroRNAs involved in the EGFR pathway in glioblastoma.Biomed Pharmacother. 2021 Feb;134:111115. doi: 10.1016/j.biopha.2020.111115. Epub 2020 Dec 16. Biomed Pharmacother. 2021. PMID: 33341046 Review.
References
-
- WHO Classification of Tumours Editorial Board (2021) World Health Organization. Classification of Tumours of the Central Nervous System
-
- FERNANDES C, COSTA A, OSÓRIO L, LAGO RC, LINHARES P et al (2017) CARVALHO B,. Current Standards of Care in Glioblastoma Therapy. In: Glioblastoma. Codon Publications; pp. 197–241
-
- Chen Z, Hambardzumyan D (2018) Immune Microenvironment in Glioblastoma subtypes. Front Immunol. 9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous